nuBioAge's Clinical Longevity Summit Sets New Standards in Post-COVID Care and Treatment

nuBioAge's Clinical Longevity Summit 2025

In September 2025, the Hilton West Palm Beach was the venue for the Clinical Longevity Summit (CLS), organized by nuBioAge. This significant event took place over two days, focusing on the extensive aftermath of COVID-19 on health and the advancements in longevity medicine. Top medical experts, researchers, and innovators gathered to share their strategies and insights aimed at enhancing post-COVID care, viewed through a systems biology framework.

The summit's theme, "Building Resilience in a Post-COVID World," set the stage for an impactful dialogue among practitioners in various medical disciplines. Attendees included specialists in pharmacology, cardiology, chemistry, neurology, gastroenterology, and integrative medicine. During the sessions, attendees discussed the lingering effects of COVID on the human body and the holistic strategies required to restore balance in patients suffering from its aftermath.

One of the highlights of the summit was a presentation by Dr. Robin Rose, a renowned COVID researcher. Dr. Rose delved into how the pandemic has altered biomarkers, increased inflammation, and contributed to long-term disease risks. Furthermore, she addressed the persistence of spike proteins and their ongoing impact on health. As a pivotal part of her discussion, Dr. Rose introduced Dr. Simone Cristoni, a chemist from ISB Ion Source and BioTechnology RD Labs, who unveiled groundbreaking diagnostics. These diagnostics can differentiate between vaccine-derived and wild-type spike proteins, thereby facilitating personalized treatment regimens.

Dr. Elizabeth Yurth, a distinguished speaker in orthopedic and regenerative medicine, emphasized mitochondrial health as fundamental to addressing multi-organ dysfunction. She illustrated how personalized peptide therapies could aid in recovery and support resilient health. Adding to the panel of experts, Dr. Cynthia Keller shared insights on the gut-health connection following COVID-19, proposing targeted compound protocols to restore immune and gut integrity for both adolescents and adults.

The summit also featured discussions led by hormone optimization expert Dr. Suzanne Feree, who addressed COVID’s influence on autonomic dysregulation and highlighted specific IV and peptide therapies that could be used for recovery. Dr. Abid Husain, a preventive cardiologist, provided insights into how conditions like myocarditis and POTS relate to endothelial damage and mitochondrial shortcomings. His findings sparked discussions about novel therapeutic strategies to target these cardiovascular syndromes.

Leonard Pastrana, PharmD, and co-founder of nuBioAge, encapsulated the purpose of the conference with the statement, "This summit is about more than recovery; it's about reshaping our approach to medicine in a post-COVID environment." He stressed the importance of building a resilient healthcare framework that focuses on longevity and well-being. The CLS concluded with a dynamic Q&A session featuring the nuBioAge Scientific Team, who examined the interconnections between gut health, mitochondria, immune response, cardiovascular, and neurological health, vital for holistic recovery in post-COVID patients.

Besides the rich panel discussions, various exhibitors showcased innovative services and products aimed at improving patient outcomes post-COVID. Noteworthy among them were companies specializing in respiratory analysis, biomarker testing, and pharmacological advances. NuBioAge also took the opportunity to introduce a new supplement partnership with Vedicinals9, designed to enhance immune resilience coupled with cellular energy for recovering patients.

Attendees expressed their gratitude for the conference, noting the lack of established post-COVID protocols prior to the summit. Wandy Schlaug, NP from Crestwood, Kentucky, remarked how the conference provided vital science-backed treatments that she planned to implement in her practice. Another attendee, Dr. Marcos de Andrade, found the learning experience transformational, bringing new approaches to the forefront in treating long-COVID conditions.

As the summit wrapped up, nuBioAge announced their upcoming event, CALM (Clinical Application of Longevity Medicine), scheduled for February 27-28, 2026, in Fort Lauderdale, Florida. This future endeavor will further their mission to empower healthcare practitioners in the evolving field of longevity medicine. For additional insights and updates about nuBioAge, including their supplements and certification courses in peptide therapy, visit their official website at nubioage.com.

About nuBioAge

nuBioAge is a pioneering longevity science and wellness network dedicated to educating medical professionals on patient-centric, evidence-based longevity medicine. With a focus on merging advanced pharmacy networks and clinical practices, nuBioAge aspires to be the premier source of longevity education and care, ensuring improved health outcomes through innovative approaches in medical science.